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Abstract  
 
This paper investigates environmental sustainability dynamics of an industrial system 
through a case study on the UK Medical Technology sector. This paper builds on an 
industrial system framework involving institutions, specialist firms, value/supply chains 
and industrial actors. Environmental sustainability dynamics are explored through 
infrastructure and structure factors of industrial systems that are primarily developed 
from theoretical domains of manufacturing systems, production networks and supply 
chains. Research findings suggest that structural components influence the industry 
system more radically than the infrastructural components. Environmental sustainability 
dynamics depend on the size of industrial actors, types/characteristics of product and 
process, and availability of specialist (funding/technology) firms.  
 
Keywords: 1) Sustainability in Operations and Logistics, (2) Healthcare Operations 
Management, (3) Supply Network Design 
 
 
1 Introduction 
 
Environmental sustainability has been described as one of the greatest challenges over 
the coming decades. In 2008, the UK government passed the ‘Climate Change Act’, 
requiring an 80% national reduction in greenhouse gas emissions by 2050 based on a 
1990 baseline, supported by reductions of 34% by 2020 and 50% by 2025. It is 
suggested that 30% or more of the GHG generated is due to the inefficiencies of 
industrial systems in developed countries (Evans, Bergendahl, Gregory, & Ryan, 2009). 
This implies that there is a need to approach sustainability from a systems view in order 
to understand the environmental sustainability dynamics (Seuring & Gold, 2013). These 
dynamics can be explained by understanding what influences a complex industrial 
system for environmental sustainability and how (Forrester, 1958). Therefore, this paper 
addresses the research question – How can an industrial system be influenced to 
develop environmental sustainable operations? 
 
2 Theoretical foundation 
 
2.1 Industrial system 
 
Manufacturing systems have evolved from simple raw material transformation in a 
factory to a highly complicated industrial system that “Include(s) the context, resources, 
activities, processes, actors, and interdependencies that support the creation and 
delivery of products and services”(Kumar & Gregory, 2013; RAC, 2012). Today, the 
actors involved in manufacturing not only include the global industrial actors, but other 
external stakeholders. Theoretical work on clusters, business ecosystems and industry 
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structure have highlighted the importance of institutions (e.g. through research, 
policy/regulation, knowledge transfer) and specialists (e.g. through funding, specialist 
equipment, technical support and services) that support an industry (Kumar, Srai, 
Pattinson, & Gregory, 2013; Luo, Whitney, Baldwin, & Magee, 2011; Porter, 1998; 
Srai, 2010; Srai, Christodoulou, & Harrington, 2014). This research draws on industrial 
system frameworks with multiple subsystems/levels including institutions and 
specialists, Industrial Value/Supply Chain (VC/SC), core process/products and 
industrial actors (Figure 1).  
 
 
Figure 1: Industrial System Framework developed from (Kumar et al., 2013; Srai 2010; Srai et al., 2014)  
 
 
 
 
2.2 Dynamics or influences in Industrial systems  
 
Skinner was one of the earliest pioneers to look more closely at manufacturing 
involving a pattern of individual decisions and their influences to meet long term 
company objectives (Skinner, 1969). This view was expanded by Hayes and 
Wheelwright to observe manufacturing from a factory system perspective by 
considering the structural (capacity, facilities, technology, vertical integration) and 
infrastructural (workforce, quality, planning/control, organisational structure) elements 
(Hayes & Wheelwright, 1984). Generally, these two types of elements are 
interdependent but have different characteristics. Theoretically, changes in any or all of 
the structural and infrastructural elements reconfigure or transform a system.  The 
structure has a more radical and architectural influence on the system, whereas the 
infrastructure determines daily operations as well as accumulative improvements (Shi & 
Gregory, 1998). Therefore, if we can develop the infrastructural and structural elements 
of an industrial system then we can observe dynamics – environmental dynamics, 
specifically in this research. 
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During the late 1990’s, further emphasis on the geographical location and coordination 
of factories was cited by Shi & Gregory, leading to the international manufacturing 
perspective (Shi & Gregory, 1998). In 1999, the importance of globalisation in co-
operative and inter-organisational supplier relations was highlighted, leading to the 
theory of a supply chain as a system (Harland, Lamming, & Cousins, 1999). Today, the 
actors involved in manufacturing not only include the global industrial actors, but other 
external stakeholders as well. Literature on clusters, business ecosystems and industry 
structure have highlighted the importance of institutions (e.g. through research, 
policy/regulation, knowledge transfer) and specialists (e.g. through funding, specialist 
equipment, technical support and services) that support an industry (Porter, 1998; 
Brusoni et al., 2009; Whitney et al., 2011). Additionally, an industrial system 
perspective extends supply chain to value chain, including upstream (R&D and design) 
and downstream (market use and end of life/after sales service) to capture the entire 
range of industrial activities necessary for the provision of goods and services 
(Sturgeon, 2001). Although the end of life process such as waste management has a 
different nature to that of other industrial systems, it is an integral part of any 
manufacturing system and its importance is emphasised (Ellen Macarthur Foundation, 
2013). 
 
Building on the evolving nature of structure and infrastructure components discussed by 
authors such as Hayes & Wheelwright and Shi & Gregory, a new set of constructs for 
an industrial system is proposed, shown in table 1 & 2. It is important to note that 
companies traditionally take decisions influencing the structure and infrastructure of 
manufacturing systems. Whereas in an industrial system, a mixture of external 
stakeholders and industrial actors make these decisions.  
 
 
Table 1 Evolution of Structural/Infrastructural Constructs of a System 
System Types  Structure (Architecture)  Infrastructure (Mechanism) 
Factory  Capacity 
 Facilities 
 Technology 
 Vertical integration 
 Workforce 
 Quality 
 Planning / control 
 Organisational structure 
(Hayes & Wheelwright, 1984) 
International Manufacturing 
(Shi & Gregory, 1998) 
 Factory's characteristics 
(above) 
 Geographic dispersion 
 Horizontal coordination 
 Vertical coordination 
 Dynamic response mechanism 
 Learning / knowledge transfer 
 Operational mechanism 
 / network evolution 
 
Supply Chain  Capacity 
 Role configuration 
 Facility configuration 
 Make or buy 
 SC HR policy 
 Supplier Quality 
 Planning / control 
 Organisation structure 
 New product development 
 Performance measurement 
(Harland et al., 1999) 
Industrial System   Product/service 
characteristics 
 Industrial Actors 
 Product/Service Quality (Porter, 1998; Sturgeon, 2001; 
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Moore, 2005; Jacobides et al., 
2006; Porter, 2007; Brusoni et 
al., 2009; Evans et al., 2009; 
Whitney et al., 2011; The 
Royal Academy of Engineering, 
2012; Srai & Christodoulou, 
2014) 
 VC/SC processes 
 Capacity (including R&D, 
Production, import/export 
etc.) 
 Roles and relationship 
between institutions, 
specialists, VC/SC and 
industrial actors 
 Technology 
 New product/process 
development 
 Institutions/Specialist 
involvement (e.g. policy, 
regulation, knowledge 
transfer) 
 
Table 2 Description of Proposed Industrial System Structure/Infrastructure 
Name Description 
Product/service characteristics Technology basis, number of components, materials used, 
overall value, purpose etc. 
Value/supply chain (VC/SC) processes R&D, design, supply chain development, production, 
distribution, market, end of life/after sales service 
Capacity Total volume that an industrial system can have in its 
VC/SC processes, including imports/exports 
Roles and relationship Role of a certain actor type and its relationship within the 
industrial system (nature of behaviour with others)  
Technology Technology that determines how a product/service can be 
produced and communicated with various actors 
Industrial actors Actors involved at the various part of the VC/SC 
Product/service quality Overall quality of the service offered (e.g. minimum 
requirement generally set by regulators) 
New product/process development New product, VC/SC process, strategies, policies, etc. 
Institutions/specialists involvement External stakeholders that have an influence on an 
industrial system (e.g. government, funding, regulatory 
bodies) 
 Source: Developed from Table 1 
2.3 Environment sustainability 
 
Environmental sustainability has been described as one of the greatest challenges over 
the coming decades. It is suggested industrial systems are responsible for 30% or more 
of Green House Gas (GHG) generated in industrial countries (Evans et al., 2009). 
Literature has emphasised the importance of systems thinking when considering 
sustainability. This implies that there is a need to approach sustainability from a systems 
view in order to understand the dynamics and implications of different environmental 
activities (Anarow et al., 2003; Evans et al., 2009; Seuring & Gold, 2013). Various 
authors have proposed that in order to achieve industrial sustainability, activities 
targeted at multiple levels or sub-systems are necessary (Chertow, 2000; Fiksel, 2003; 
Braungart et al., 2007; Marchi et al., 2013). Following this view, fragmented literature 
on environmental activities were reviewed and categorised into three levels defined in 
the industrial system analytical framework:  
 
 Institution/Specialist: Activities focused on influencing the overall industrial 
system 
 Value/Supply Chain (VC/SC): Activities focused on influencing at inter-firm 
level 
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 Industrial Actor: Activities focused on influencing in-house products/processes 
 
2.3.1 Institution/Specialist Level Environmental Activities 
 
Environmental Sustainability Concepts: Industrial ecology is one of the most commonly 
referred environmental sustainability concepts. The study is based on simulating a 
biological ecosystem by shifting an industrial process from a linear (open-loop) system 
to a circular (closed-loop) system to reuse waste (Frosch & Gallopoulos, 1989; Garner, 
1995). Models based on this concept can have either a focus on the product and its 
material flow or in defined geographical locations (Boons & Baas, 1997). Cradle-to-
cradle (C2C) is one of the most proactive frameworks focusing on the product side. It 
aims to maintain or even upgrade resource quality and productivity through many 
cycles of use by having different processes for the ‘biological nutrients’ and ‘technical 
nutrients’. Biological nutrients can be decomposed and allowed to re-enter the natural 
system, while technical nutrients should be kept within the system and used multiple 
times. (Braungart & McDonough, 2002; Braungart et al., 2007). Industrial symbiosis or 
eco-industrial park is a model focused on the geographical location that involves two or 
more industrial facilities in relative geographic proximity that share energy, materials, 
or information (Chertow, 2000; Martin & Eklund, 2011). 
 
The concept of zero waste/emission is to maximise recycling, minimise waste/emission, 
reduce consumption and ensure that products are planned to be recovered internally or 
externally (Glavič & Lukman, 2007). The ultimate goal is to produce no waste in air, 
water and land (Gravitis et al., 2004). In contrast to C2C, the approach is rather reactive 
in that it seeks to reduce the unintended negative consequences of processes of 
production and consumption (Braungart et al., 2007).  
 
Environmental Policy/Strategy: Most environmental ministries in the industrialised 
countries were set up during the early 1970’s (Martin, 1992). Since then, there has been 
a gradual development of the environmental policies that are in line with a certain 
sustainability concept. For example in 1973, Ministry of International Trade and 
Industry in Japan officially recommended a new policy to be developed on the basis of 
industrial ecology principles. This led to a strategy that aimed to reduce dependency on 
material resources through technology advancement (Erkman, 1997). Both national and 
international policies used to focus primarily on how to make production more 
environmental, rather than on consumption. This imbalance has been readdressed and 
now there is a greater emphasis on sustainable consumption, defined as: 
 
“The use of goods and services that respond to basic needs and bring a better quality of 
life while minimising the use of natural resources, toxic materials and emission of waste 
and pollutants over the life cycle, so as not to jeopardise the need of future 
generations” (Southerton et al., 2004; Seyfang, 2006).  
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Environmental Legalisation / Schemes: Environmental legalisation is a set of legal 
principles, acts, regulations, directives, and laws aimed to implement environmental 
policies (Glavič & Lukman, 2007). For example, the European Union (EU) 
Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) 
regulation restricts the use of certain chemicals in various industries within its member 
states. There is also an indirect impact on domestic environmental law in many other 
countries (e.g. USA) since the modern supply chain is highly global (DG ENTR, 2007; 
Yang & Percival, 2009). Another role of environmental regulation is to force or 
facilitate the adoption of environmental innovation, however there is a significant 
barrier in doing so (Murphy & Gouldson, 2000). 
 
Another method of influencing the industry as a whole is through voluntary schemes. 
ISO 14001 is one of the most commonly used standards from the International 
Organization of Standardization (ISO) regarding Environmental Management System 
(EMS) to support sustainable development. Nearly 8000 organisations in 72 countries 
had been certified by 1998 (Rondinelli & Vastag, 2000). One of the main concerns 
regarding standards is its lack of legitimacy. Companies may be using standards merely 
as an image-building or public relations effort. With ISO 14001, it is difficult to 
influence the industry at a system level as the certification is facility specific and it does 
not have an influence amongst the facility’s suppliers for example (Kleindorfer et al., 
2005; Mueller et al., 2009).  
 
 
2.3.2 Value/Supply Chain Level Environmental Activities 
 
Green Value/Supply Chain Management: In this system level, much of the literature 
focuses on green supply chain management (GSCM). It is important to note that many 
authors refer to the extended supply chain (e.g. includes product design and end-of-life 
management) when discussing sustainability in this area. This is mainly due to the focus 
on adopting sustainability models such as C2C or closed-loop systems (Kleindorfer et 
al., 2005; Srivastava, 2007). GSCM must be viewed as managing environmental 
activities of two or more transacting organisations. An organisation can either choose to 
get directly involved with its supply chain members (e.g. investing own resources) or 
use existing frameworks/market mechanisms to influence them (e.g. ISO 14001 as a 
supplier evaluation criteria for procurement) (Vachon & Klassen, 2006). 
 
From the influence of environmental sustainability concepts such as closed-loop aspect 
of industrial ecology, there is a great emphasis on the downstream operations (e.g. 
reverse logistics, waste management) within GSCM literature. Aspects of reverse 
logistics include: collecting, inspection/sorting, pre-processing, location and  
distribution as well as network design (Srivastava, 2007). In comparison to the 
traditional supply chain management, it requires more coordination with immediate 
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customers/end-consumers along with greater interaction with suppliers (Vachon & 
Klassen, 2006). 
 
Environmental Collaboration: Collaborative mechanisms are becoming more important 
for industrial organisations from schemes such as extended producer responsibility. 
Legislation such as Waste Electronics and Electrical Equipment (WEEE) from the EU 
requires manufacturers to ensure the safe handling of their product’s materials after the 
customer use phase. Generally, the producer links the different actors involved in the 
product’s life cycle through coordinated collaboration as well as with other product 
manufacturers (Gottberg et al., 2006; Braungart et al., 2007).  
 
Other examples of collaborative mechanisms include knowledge sharing activities 
regarding greener product design, process modification and reducing waste in the 
logistics process (Vachon & Klassen, 2006). Marchi et al. (2013) has also discussed the 
importance for original equipment manufacturers (OEMs) to collaborate with their 
suppliers as well as key institutions and specialists (e.g. universities and service firms) 
to create and share new environmental knowledge on green product or processes. 
 
2.3.3 Industrial Actor Level Environmental Activities 
 
Eco Design : Eco design is a product development process that takes account of the 
total life cycle stages in order to minimise environmental impact through design 
(Srivastava, 2007). There are various aspects that are involved ranging from different 
product recovery methods, dematerialisation and alterative material/chemistry, shown in 
table 3. In the case of consumer electronics, the ease of disassembling a product at the 
end of life is a key concept for the manufacture due to the extended producer 
responsibility from the WEEE legislation (Platcheck et al., 2008). The product design 
phase can account up to 80% of the environmental sustainability factors, highlighting 
the importance of eco design (Maxwell & van der Vorst, 2003).  
 
Product Recovery: Product recovery refers to the range of activities aimed to reclaim 
value from a product at the end of its life cycle (Srivastava, 2007). It is an important 
aspect of industrial ecology or other industrial level environmental activities. Recycling 
is one of the most commonly used forms of recovery methods. It is defined as the 
resource recovery method through collection and treatment of waste products to be used 
as raw material in the manufacture of the same or a similar product (Glavič & Lukman, 
2007). Within recycling, it is important to distinguish between upcycling and 
downcycling. The former involves the upgrading of waste materials into more valuable 
products, contributing to the idea of C2C (Braungart et al., 2007; Pol, 2010). The latter 
implies a downgrade in material quality, limiting usability and it is part of cradle-to-
grave (open-loop system) in contrast to C2C (Braungart et al., 2007). 
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Green Production: There are different forms of environmental production methods 
within literature. One of the more proactive approaches is cleaner production. 
Compared to the rather reactive end-of-pipe practices, this method encompasses 
dematerialisation and pollution prevention at the source, rather than waste minimisation 
and pollution control at the end of process (Glavič & Lukman, 2007; Wang & Côté, 
2011). Examples of cleaner production technologies include using environmentally 
friendly materials (e.g. replacing organic solvents by water) and modification of the 
combustion chamber design (Frondel et al., 2007). In any green production methods, the 
use of efficiency techniques (e.g. lean, total quality management) as well as the use of 
by-products (e.g. waste heat) are commonly found (Kleindorfer et al., 2005; Linton et 
al., 2007). 
 
Green Corporate Policy/Strategy: General corporate policies can be divided into eco-
effective or eco-efficiency oriented ones. Eco-effective policies are the backbone of 
C2C or industrial ecology concepts that aims to enable upcycling, which is not only the 
redirection of material flow, but also the establishment of new forms of supportive 
information and finance flow networks (Braungart et al., 2007). In contrast, eco-
efficiency oriented policies relates to downcycling, creating less waste and pollution, 
therefore supporting environmental concepts such as zero waste/emission (Orsato, 
2006; Wang & Côté, 2011). 
 
Within strategies, companies can engage environmental sustainability in a proactive 
manner (e.g. beyond compliance/environmental leadership strategy) or in a reactive one 
(e.g. environmentally neutral/responsive strategy) (Orsato, 2006; Baines et al., 2012; 
Marchi et al., 2013). There are also new types of strategies emerging. One example is 
the product service system (PSS) strategy based on dematerialisation principle by 
leasing products (e.g. ‘power-by-the hour’ strategy by Rolls Royce) rather than selling 
them. It is noted that collaboration with customers and suppliers as well as the 
supporting structure/infrastructure is an important aspect for an effective PSS strategy 
(Tsoulfas & Pappis, 2006; Baines et al., 2007). Others include compliance with 
regulations due to influences of institutional level environmental activities and 
renewable energy sourcing through industrial incentives (Jacobsson & Lauber, 2006; 
Tsoulfas & Pappis, 2006). 
 
In support of the corporate policies and strategies, organisations often use tools such as 
energy, resource, waste and carbon (ERWC) framework and life cycle assessment 
(LCA) for environmental accounting purposes. ERWC framework is based on 
measuring the factory level environmental impact via carbon footprint, considering 
energy efficiency, resource utilisation and waste minimisation (Tridech & Cheng, 
2010). LCA considers total environmental impact of the used materials, energy inputs, 
wastes, and emissions from the production of the first raw material to the final 
disposition of the manufactured product (Joshi, 2000). 
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Environmental activities in the above three levels gathered from literature are shown in 
table 3. Some of these activities are repeated in multiple systems due to its relevance in 
more than one level. It is important to mention that these activities have different 
perspectives. VC/SC level has a higher focus on the activities requiring collaboration 
with multiple actors, whereas industrial actor level is primary in-house activities. For 
example, green/eco design can be done through both collaborations or individually. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 11 
 
Institution/ Specialist Level Industrial Actor Level 
Environmental Sustainability Concepts Source No. Eco Design Source No. 
Industrial ecology 1,2,6,10,27 Design for material and product recovery 5,13,14 
- industrial ecosystem 1,,10,12 Design for disassembly 14,15,18 
- industrial symbiosis/ Eco-industrial park 1,26,27,28 Design for waste minimization 1,19 
- Circular economy 38,39 Design for remanufacturing 1,5,14 
- Cradle to cradle 1,11,12 Design for recycling issues 1,5,14 
Zero waste/ zero emission 1,12,40 Design for dematerialisation 1,21 
Environmental Policy/ Strategy Source No. Design for reuse /  modularity 17,20 
Environmental Policy 49,59,51,52 Design for product life extension 19,29 
- Sustainable production/ green operation 1,6 Design under legislation and regulation 16,19 
- Sustainable consumption 1,46,53 Packaging design 17,22 
Industrial pollution prevention strategy 2,6 Better choices of material 23,24,35 
Product service system strategy see right Green chemistry 1,2,6 
Life cycle assessment see right Product Recovery Source No. 
Renewable energy sourcing see right Recycling 1,6,29 
Environmental Legalisation/ Schemes Source No. - upcycling 25,26 
Environmental regulation 16,19,47,50 - downcycling 12,27 
Environmental Standards 8,41 Reuse 1,6,29 
- ISO 14001 1,2,8,41,45,48 Repair 1,6,29 
- Eco-management and auditing scheme (EMAS) 1,42,43,45 Regeneration 1,28 
- Responsible care 1,45 Refurbish 6,7 
Voluntary environmental 1,42 Remanufacturing 1,5,6,29 
Value/ Supply Chain Level Dis-assembly 6,29 
Green value/ Supply Chain Management Source No. Green Production Source No. 
Green design see right Cleaner production 1,5,10,31 
Green procurement 9,37 End of pipe practise 1,31,32 
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Green manufacturing (inc. product recovery) see right Pollution prevention 1,32 
Green logistics 6,9,16,17 Waste minimization 1,6 
Green network 6,9,12,16 Quality / lean/ TQM / JIT techniques 5,8 
Green waste management 6,17 Use of by-product (e.g. waste heat) 5,8 
Green strategy 1,2,4,5,6,9 Green Corporate Policy / Strategy Source No. 
Product life extension 5,17 Eco-efficiency 1,4,12,11,12 
Life cycle assessment see right Eco-effectiveness 10,11,12 
Environmental Collaboration Source No. Environmentally neutral / responsive strategy 30 
Extended producer responsibility 12,19 Beyond compliance / environmental leadership strategy 4,8,30,33 
Intelligent material pooling 12 Eco branding strategy 4,33 
Shared risk and benefits/ knowledge sharing 9,33 Environmental cost leadership strategy 4,33 
    Selection of pollution prevention strategies 1,2,6,9 
    Product service system strategy 1,5,17,54 
    
Implementation of environmental management system / 
regulatory compliance 1,2,8,9,17 
    Renewable energy sourcing 34,36 
    Environmental accounting 1,17 
    - Life cycle assessment 1,2,3,5 
    ERW framework 55,56 
    Application of quality / lean / TQM / JIT principle 5,8,9 
 
Table 3: Environmental sustainability activities (Refer sources in appendix 1) 
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3 Approach  
Due to the focus on the emerging phenomena of understanding environmental dynamics 
within an industrial system, a case study methodology is selected. As the focus of this 
research is on environmental sustainability dynamics within an industrial system, 
various complex relations are investigated between external stakeholders, processes and 
industrial actors. The primary focus of this research is on the industrial system 
characteristics and its dynamics with environmental sustainability. Therefore multiple 
case studies are chosen to analyse different sector segments to draw on its 
characteristics. Yin (1994) also states that the unit of analysis can be either: holistic – 
focus on the totality; or embedded – focus on specific units or processes. This study will 
use embedded multiple case studies since the interested units are the UKMTS industrial 
system characteristics and its environmental activities in order to evaluate the dynamics 
between the two.  
 
In order to choose the industry to apply the framework developed in Literature Review, 
selection criteria were developed, shown in Table 4. From the major UK industries, 
three industries were chosen according to the complexity of the industrial system 
structure and infrastructure. By applying the developed framework to such a complex 
industry, it is possible to fully assess the capability of this new approach. Adding to the 
complexity, UK Life Science is highly regulated with growing regulatory pressure 
(Cairns, 2014). From the three listed, Life Science industry was chosen due to its 
complexity and the low focus on environmental sustainability. From this low maturity, 
it has a potential to observe a significant influence of environmental sustainability on 
the current system.  
 
Table 4 Industry Selection Criteria 
Industry Country Structure Infrastructure Regulation / 
Env. Sustainability 
Life Science UK Complex Complex Highly regulated / 
Low focus 
Automotive UK Complex Complex Relatively less / 
High focus 
Food UK Complex Complex Least regulated / 
High focus 
 
Two product-based industrial systems in two different segments are investigated. These 
were chosen as; In Vitro Diagnostic (IVD) - tests conducted from samples derived from 
the human body such as blood and urine, and Single Use Instrument (SUI) - devices that 
are intended to be used on an individual patient during a single procedure and then 
discarded. These segments were chosen due to their significance in terms of annual 
turnover and employment. Selected products for the case studies are shown in Table 5. 
Addendum B shows further detail on the overview of UKMTS including detailed 
product descriptions.  
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Table 5 Selection of Products 
Product Segment Note 
PCR* system IVD Used for professional diagnostics (e.g. infectious 
disease) 
SMBG** system IVD Used to self monitor glucose level for diabetes 
Single use syringe SUI Used to inject substances or take samples 
Single use forceps SUI Used for various surgeries 
*PCR: Polymerised Chain Reaction, **SMBG: Self-Monitoring Blood Glucose 
 
The case study approach involved mapping the industrial system from secondary data 
and then validating these maps with primary data. Four product based industrial systems 
are mapped. The primary data are collected based on interviews. The format of the 
interview was semi-structured rather than structured due to the nature of this study 
requiring interviews from various actors. Key stakeholders to interview were chosen 
from the institutions, specialists and industrial actors identified from the initial 
industrial system map development process. On average, 45 min interviews were 
conducted with a total of 19 interviewees. The positions of the interviewees ranged 
from high level (e.g. managing director, head of department) to general managers (e.g. 
R&D, quality, regulatory). Data analysis was structured around key concepts derived 
from the literature. With-in-case analysis and cross case analysis was performed to 
identify key evidence of environmental sustainability influences and  within an 
industrial system, along with pattern matching for environmental sustainability 
influences which helped to link the data with the key findings (Figure 2 and3; Table 6, 
7, 8 and 9).  
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Figure 2: Influence of environmental sustainability at the institution and specialist levels 
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Figure 3: Influence of environmental sustainability at the Value Chain and Industrial Actor levels 
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Table 6: Structure and Infrastructure of UKMTS Industrial system – In Vitro Diagnostic Segment 
 
    
In Vitro Diagnostic Segment 
PCR System SMBG System 
St
ru
ct
u
re
 
Product Characteristics     
Technology biotechnology, electrical, mechanical 
No. components very high high 
Components/materials 
used 
mix of plastic, metal, electronic component, LCD screen, internal computer, sensors, (bio)chemicals etc. 
value high medium 
Purpose diagnostic/research diagnostic 
VC/SC Processes   
R&D, Design complicated (esp. diagnostics reagent) 
Pre-market Approval 
CE approval route depends on its use (research 
diagnostic) 
device and test strip follows IVDD route whereas a 
lancet follows the MDD for CE approval 
Supply Chain Development complex due to various components/material required for both instrument and reagent 
Production Variety of production stage involved (machining, assembly, chemical processing etc.) 
Distribution Mainly through direct to market from OEMs/OBMs, NHS Supply Chain or other distributors 
Market 
public/private healthcare, university /labs, 
biotech/pharma companies etc. 
mainly public / private healthcare and pharmacies 
End of life / After Sales 
Service 
refurbish/remanufacturing/reuse, recycling, 
incinerate/landfill 
recycling, incinerate/landfill 
Capacity   
R&D, Design relatively high capacity from industrial actors as well as external stakeholders 
Pre-market Approval higher capacity due to emerging sector 
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Supply Chain Development 
low capacity for reagents (mainly from Europe) 
moderate capacity for research use instrument (sourced 
locally) 
n/a 
Production higher production capacity on reagents 
Distribution highest capacity through direct to market 
Market higher reagent capacity than instrument (esp. research use in the case of PCR) 
End of life / After Sales 
Service 
highest capacity on recycling 
Product Imports/Exports 
higher import capacity than exports (some reagent 
exports) 
almost exclusive imports for UK market (some 
reagent exports) 
Roles and Relationship   
Institutions various interactions within different institutions as well as with industrial actors 
Specialists 
various  interactions with a specific player of the value chain as well as with industrial actors (e.g. direction of 
research funding) 
Industrial Actors 
main interactions with suppliers/customers as well as with stakeholders (e.g. research partnerships, regulation, 
lobbying) 
Technology   
Production mainly manual method (e.g. mixing, machining) involved 
mix of manual (for device) and automated (for test 
strip) 
Communication mix of IT and manual data communication 
In
fr
as
tr
u
ct
u
r
e 
Industrial Actors   
R&D, Design mix of MNCs, SMEs and ODMs 
Pre-market Approval generally more parties involved (e.g. NICE, MHRA) due to the innovative nature of the devices 
Supply Chain Development low US based supplier from most production occurring globally 
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Production 
high ratio of geographical presence of MNCs although 
only on company with production facility in the UK was 
observed 
moderate ratio of UK OEMs for reagent production 
high ratio of geographical presence of MNCs 
although only one company with production facility 
in the UK was observed  
very few UK OEM presence 
Distribution Similar actor types (OEMs, OBMs for direct to market, NHS Supply Chain and other distributors) 
Market 
Various users involved due to the multiple device use 
nature (diagnostic of research) 
  
End of life / After Sales 
Service 
Various actors involved due to many end of life options   
External Stakeholder 
Involvement 
  
Institutions 
high involvement of product related research (mainly biotechnology rather than mechanical/electrical 
high  involvement of global health NGOs due to epidemic nature of immunology / diabetes 
focus of regulation is due to the risk of devices from the interpretation of test results 
legislation difference between diagnostics and research 
use devices (IVDD vs. EMCD & LVD) 
further focus on accuracy of data and reliability due 
to self-testing nature of product (ISO 15197) 
Specialists more commercial findings are available and more component/ equipment manufactures  
  
relatively complex overall notified body involvement due 
to difference in device use 
relative complex overall notified body involvement 
due to difference in component purpose 
Product / Service Quality   
Quality 
high quality is maintained through strict regulations and  quality management standards (e.g. ISO 9001/13485) 
due to concern on health & safety of patients 
New Product / Process 
Development 
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New Product 
focus on next-generation sensing technology, safety and 
comfort 
focus on next-generation sensing technology, safety 
and comfort 
New Process 
new process to prepare for the new IVD, MD Directive 
(ongoing review since 2012) 
new process to prepare for the new IVD, MD 
Directive (on-going review since 2012 
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Table 7: Structure and Infrastructure of UKMTS Industrial system – Single Use Segment 
 
    
Single Use Segment 
Single Use Syringe Single Use Forceps 
St
ru
ct
u
re
 
Product Characteristics     
Technology mechanical 
No. components low few 
Components/materials 
used 
mix of plastics, rubber, metal etc., metal (e.g. stainless steel) 
value low 
Purpose clinical 
VC/SC Processes   
R&D, Design moderate simple 
Pre-market Approval both follows the MDD route for CE approval   
Supply Chain Development relatively simple since several components/materials required simple due to only metal in required 
Production main production stages include needle and plastic moulding various different machining stages (mainly outsourced) 
Distribution Mainly through direct to market from OEMs/OBMs, NHS Supply Chain or other distributors 
Market mainly public/private healthcare 
End of life / After Sales 
Service 
primary incinerate/landfill mix of recycling and incinerate/landfill 
Capacity   
R&D, Design relatively low low 
Pre-market Approval relatively low capacity due to established field 
Supply Chain Development n/a low capacity (mainly from East Asia and Europe) 
Production more Globally than UK low machining capacity (due to majority outsourced) 
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Distribution mix highest capacity through direct to market 
Market higher capacity for public healthcare 
End of life / After Sales 
Service 
most products follow incineration/landfill higher capacity on incineration/landfill 
Product Imports/Exports higher import capacity than exports relatively high exports 
Roles and Relationship   
Institutions various interactions within different institutions as well as with industrial actors 
Specialists 
various  interactions with a specific player of the value chain as well as with industrial actors (e.g. direction of research 
funding) 
Industrial Actors main interactions with suppliers/customers as well as with stakeholders (e.g. research partnerships, regulation, lobbying) 
Technology   
Production automated technology can used mainly manual machining 
Communication mix of IT and manual data communication 
In
fr
as
tr
u
ct
u
re
 
Industrial Actors   
R&D, Design mix of MNCs, SMEs and ODMs mix of UK OEMs and machined parts suppliers 
Pre-market Approval generally simple mechanism due to relatively simple technology involvement/long existence of devices 
Supply Chain Development n/a suppliers concentrating in East Asia and Europe 
Production 
high ratio of geographical presence of MNCs in general  
moderate ratio of UK OEM presence 
some other UK based firms (e.g. for needle production) 
high ratio of Pakistan based machined parts supplier as 
well as UK OEM/OBM presence 
some other UK based firms (e.g. for outsourced 
packaging) 
Distribution Similar actor types (OEMs, OBMs for direct to market, NHS Supply Chain and other distributors) 
Market Relatively few types involvement due to devices used predominantly by healthcare professionals 
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End of life / After Sales 
Service 
Generally only one end of life player type Multiple actors involved from more than one end of life 
External Stakeholder 
Involvement 
  
Institutions 
Research focus on health & safety aspects (e.g. decontamination) 
high involvement of regulators and trade unions regarding health & safety of product users 
focus of regulation is due to the risk of devices from the potential physical harm to the patient/users 
further focus on blood-borne disease: The Sharps Regulation 
(Sharps instruments in Health care) Regulations 2013 
further focus on reprocessing instruments 
Specialists 
  
relatively lower involvement compared to IVD a sector 
relatively complex notified body involvement from various ISO 
standards that may be applicable 
relatively simple notified body structure 
Product / Service Quality   
Quality 
high quality is maintained through strict regulations and  quality management standards (e.g. ISO 9001/13485) due to 
concern on health & safety of patients 
New Product / Process 
Development 
  
New Product 
focus on safety/shielding mechanism, new drug delivery 
methods (e.g. needle-free) 
focus on new material and customer design 
requirements 
New Process new process to prepare for the new MD Directive (on-going review since 2012) 
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Table 8: Environmental sustainability focus and challenges (Cross-case analysis) – In Vitro Diagnostic Segment 
 
  
  
In Vitro Diagnostic Segment 
PCR System SMBG System 
 Institution/Specialist Level   
Policy 
focus on green economy: encourage resource efficiency and environmental management, promotion of eco-Innovation. 
Improving the sustainable consumption. focus on waste/product recovery, and to achieve 80% GHG reduction by 2050 
Strategy 
developing medical technology industrial strategy for Climate Change National Adaptation Plan as well as more specific 
strategies regarding each product from the highlights on specific carbon hotspots (by SDU)  
Regulation 
setting regulations in line with above policy as well as ensuring a balance between health & safety aspects  
to improve product recovery (e.g. setting landfill tax (80 pounds per tonne) to divert waste from landfill and regulating 
exports to avoid leakage of valuable material)  
Funding funding research on all TRL. that support circular economy principle  
Knowledge Transfer  
to provide strategy. guidance and tools to industrial actors as well as external stakeholders to support environmental 
policies 
Lobbying 
consultation to align UK environmental sustainability polity amnion with EU level  
consultation regarding landfill taxation policy to incentivize products that are designed to have lower environmental 
impact and support greater reuse/repair  
possible Inclusion of environmental aspects in the HTA from NICE  
Value/ Supply Chain Level   
Green Manufacturing waste minimisation (MNC)    
Green Procurement  
more sustainable consumption through inclusion of carbon reduction aspects for NHS procurement (UK user)  
sustainable consumption through inclusion of IVD EEE for EU Green Public Procurement Guideline (UK user)  
Green logistics 
 
reduction of carbon footprint through achieving carbon fleet neutral through carbon reduction aspects for NHS 
procurement (UK user)  
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 Reduce waste and carbon footprint via reduction of 
refrigerant for reagent transport(MNC)    
 
Green Waste Management  
Green Strategy  
reduction of carbon footprint through investigating carbon 'hot spots' for a particular product (UK manufacture) 
increased product recovery from further bringing back sterilisation to the hospitals (e.g., Hospital StenInation and 
Disinfection Unit. HSDU) 
improved resource efficiency and wage through E-procurement strategies leading to lower via paperless system (e.g. 
UDI GSI compliant barcodes)  
Emended Producer 
Responsibility  Increase In product recovery/resource efficiency through compliance to WEEE. RoHs directive (IVD actors)  
Shared Risk and Benefits/ 
Knowledge Sharing  
overall Improvement through collaboration with other industrial actors (e.g. OEMs, NHS, waste management firms) 
(Industrial actors)  
Industrial Actors Level    
Eco Design    
Design for waste minimisation  
reducing waste from reducing power usage of 
instruments (SME)  
research and production of freeze dried reagents that 
can significantly reduce carbon fleet (SME) 
reducing waste from designing a SMBG system using 
significantly less consumables (MNC) 
reducing waste through smaller, lighter packaging (MNC) 
Package Design 
research and implementation of biodegradable 
packaging to eliminate waste (MNC)   
Better choice of material  
research and implementation of sustainable material 
(bioplastics)for reagent packaging (MNC) 
increasing product through the use of sustainable material 
for packaging materials (MNC) 
Product Recovery   
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Reuse   
Green Production   
Clean Production/Pollution 
Prevention 
increase in environmental management through using less polluting hydroclave as an alternative to incineration (end of 
life firm) 
recovering energy from incinerating healthcare waste (end of life firm) 
Green Corporate Policy/Strategy   
Eco-efficiency 
process/product improvements to reduce waste (MNC) 
Green building design and construction initiatives (e.g. LEED) 
(MNC) 
Eco-innovation through Product Stewardship strategy (MNC) 
Beyond 
compliance/Environment 
Leadership   
Renewable energy sourcing   
Selection of pollution prevention 
strategy 
online diagnostic procedures to save replacement 
carbon fleet (SME)   
Implementation of 
EMS/Regulatory compliance 
implementing EMS (e.g. ISO 14001) to a number of actors, especially SMEs and others wishing to become a waste 
management provider (can be through green funding opportunities 
implementation of EMS through the use of green funding 
(SME) 
compliance to revised regulation with anticipated 
increase in toxicity of future reagents (SME)   
Environmental accounting (LCA)   
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Table 8: Environmental sustainability focus and challenges (Cross-case analysis) – Single Use Segment 
  Single Use Segment 
  Single Use Syringe Single Use Forceps 
 Institution/Specialist Level   
Policy 
focus on green economy: encourage resource efficiency and environmental management, promotion of eco-Innovation. 
Improving the sustainable consumption. focus on waste/product recovery, and to achieve 80% GHG reduction by 2050 
Strategy 
developing medical technology industrial strategy for Climate Change National Adaptation Plan as well as more specific 
strategies regarding each product from the highlights on specific carbon hotspots (by SDU)  
Regulation 
setting regulations in line with above policy as well as ensuring a balance between health & safety aspects  
to improve product recovery (e.g. setting landfill tax (80 pounds per tonne) to divert waste from landfill and regulating 
exports to avoid leakage of valuable material)  
Funding funding research on all TRL. that support circular economy principle  
Knowledge Transfer  
to provide strategy. guidance and tools to industrial actors as well as external stakeholders to support environmental 
policies 
Lobbying 
consultation to align UK environmental sustainability polity amnion with EU level  
consultation regarding landfill taxation policy to incentivize products that are designed to have lower environmental impact 
and support greater reuse/repair  
possible Inclusion of environmental aspects in the HTA from NICE  
Value/ Supply Chain Level   
Green Manufacturing   
GHG reduction through outsourcing manufacturing 
(SME)  
Green Procurement  
more sustainable consumption through inclusion of carbon reduction aspects for NHS procurement (UK user)  
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Green logistics 
  
Green Waste Management  
reducing waste through reusable sharps bin and collaboration 
with UK users(end of life firm)  
increase in product recovery via recycling contents of single use 
syringes with collaboration with end of life firms (MNC)  
increase in product recovery through collaboration with 
UK users to segregate and recycle stainless steel via 
scrap metal (end of life firm)  
Increase in product recovery through recycling of metals 
through economic incentive (SME) reducing  
waste through reprocessing (end of life final)  
Green Strategy  
reduction of carbon footprint through investigating carbon 'hot spots' for a particular product (UK manufacture) 
increased product recovery from further bringing back sterilisation to the hospitals (e.g., Hospital StenInation and 
Disinfection Unit. HSDU) 
improved resource efficiency and wage through E-procurement strategies leading to lower via paperless system (e.g. UDI 
GSI compliant barcodes)  
Emended Producer 
Responsibility    
Shared Risk and Benefits/ 
Knowledge Sharing  
overall Improvement through collaboration with other industrial actors (e.g. OEMs, NHS, waste management firms) 
(Industrial actors)  
Industrial Actors Level    
Eco Design    
Design for waste minimisation  
reducing waste/carban emission through designing syringes with 
much lower plastic content (MNC)   
Package Design   
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Better choice of material    
reduction in carbon footprint through research to 
substitute stainless steel into polymer to justify on-
shoring via automation (SME) 
Product Recovery   
Reuse   
Future research on reprocessing in order to assess its 
contamination issue 
Green Production     
Clean Production/Pollution 
Prevention 
increase in environmental management through using less polluting hydroclave as an alternative to incineration (end of life 
firm) 
recovering energy from incinerating healthcare waste (end of life firm) 
Green Corporate Policy/Strategy   
Eco-efficiency   
Beyond 
compliance/Environment 
Leadership   
Renewable energy sourcing   
Selection of pollution prevention 
strategy   
Implementation of 
EMS/Regulatory compliance 
implementing EMS (e.g ISO 14001) to a number of actors, especially SMEs and others wishing to become a waste 
management provider (can be through green funding opportunities 
  
Environmental accounting (LCA) 
performing LCA to investigate the trade-off between benefit 
gained from recycling, additional transportation and 
refurbishment of material, etc.(MNC) 
LCA  activities to compare carbon footprint of 
outsourcing manufacturing to UK manufactured goods 
(SME) 
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4 Discussion  
 
4.1 UK Medical Technology Sector Industrial System 
4.1.1 Structural Characteristics 
 
Product Characteristics: Both PCR system and SMBG system in the IVD segment are 
based on a number of technologies (electrical, mechanical and biotechnology) due to the 
product nature involving an instrument and a reagent. This results in a high number of 
components and materials used; plastic, metal, electronic components, LCD screen, 
internal computer, sensors, (bio) chemicals etc. Both products are used for a diagnostic 
purpose, however the PCR system is used heavily for research as well. For the single 
use segment, both syringe and forceps are mainly mechanical technology based. 
Compared to the forceps involving only stainless steel, a syringe involves a mix of 
plastic, rubber, metal etc. Both products are low value compared to the IVD products 
analysed and it is mainly used for clinical purpose in public/private healthcare. 
 
Value/Supply Chain Process, Capacity and Technology: From the two case studies on 
the IVD segment, it was observed that the VC/SC processes involved were complex in 
comparison to the SUI segment due the various technologies and the number of 
components involved. One difference between the two IVD products was found in the 
pre-market approval stage. PCR system will follow a different CE approval route 
depending on its intended use for research or diagnostic, in which the latter involves a 
more rigorous process through IVDD from the health & safety risk of the patients. 
SMBG system involves two routes as well, in which the device/test strip has to comply 
with the IVDD, whereas the lancet follows the MDD route from the different risks it 
poses to the patient.  
 
From the number of components involved for the two IVD products, a complicated 
component/material sourcing and a variety of production stages (e.g. machining, 
assembly, chemical processing) are involved. For a PCR system, materials for reagents 
are mainly sourced from a variety of suppliers in Europe resulting in a low UK capacity. 
However, components for the research use instruments are sourced locally where 
possible, resulting in a higher capacity. For production, there is a difference in structure 
in which there are more reagent OEMs, resulting in a higher capacity for them. 
Although there are many similarities between the two IVD products, one difference is in 
the reagent production technology. It was stated by an R&D Manager of a PCR Reagent 
Manufacture, “Even in a MNC, manual mixing methods are common”, whereas 
automation is common for SMBG test strips (Gebel, 2012). Another difference between 
the two is that PCR reagents generally require a refrigerated transport through inclusion 
of dried ice. 
 
The products share a common market of public/private healthcare for clinical diagnostic 
purpose. There are additional markets involved for both products in which; PCR system 
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is used in universities/labs or biotechnology/pharmaceutical companies for research, and 
SMBG system is sold in pharmacies for general public use. In both cases, there is a 
higher market capacity for the reagents rather than instruments due to its consumable 
nature. At the end of life, both instruments are most commonly recycled due to the 
WEEE legislation. In some cases, it was stated from a Clinical Waste Manager of a 
Waste Management Provider, “Some SMBG devices will go directly into incineration if 
not sterilised”. Furthermore, there was some indication of 
refurbish/remanufacturing/reuse for the PCR instruments. Reagents from both products 
as well as the lancet from the SMBG system are considered clinical waste and these are 
incinerated by high temperature and sent to landfill. 
 
From the two case studies on the SUI segment, it was observed that the VC/SC 
processes involved were relatively simple in comparison to the IVD segment. For 
example, the R&D and design phase of a single use forceps is generally based on an 
alteration of reusable instruments, stated by a Managing Director of a UK forceps 
manufacture. One difference between the two products is that syringe involves 
automated production process whereas forceps go through various manual-machining 
processes. This brings interesting production capacity differences. Forceps machining is 
mostly outsourced in Pakistan or China due to cost differences, whereas syringes can be 
produced in the UK since automation results in marginal cost difference. A Managing 
Director in a Forceps Manufacturer has stated, “If there exists a plastic with a very 
similar properties to the currently used metal that we can manufacture in the UK using 
automation that will be my Nirvana”. Both products are mainly used in public 
healthcare (NHS) and they are predominantly incinerated due to contamination. 
Although uncommon, forceps can be recycled if they are segregated as the point of use. 
In Addenbrooke’s Hospital, it was stated by an Environmental Manager, “Forceps are 
put into a separate transport box that will be sent for decontamination in-house and sent 
for scrap metal”. 
 
Roles and Relationship: Roles and relationships between institutions, specialists and 
industrial actors are very similar for all product-based industrial systems. Governmental 
bodies generally influence the research institutions and regulatory agencies via funding 
and policies. There is also a significant influence to the direction of polices via lobbying 
from industrial associations/unions (voice of industrial actors/general public) and 
Global Health NGOs (global health concern). The research funding mechanism can be 
divided into three types; research councils that fund basic research, research institutes 
that fund applied research and specialist funding bodies that fund potential 
commercialisation research. Depending on the level of research, there are frequent 
partnerships with NHS, universities and industrial actors.  
 
The primary role of the regulatory agency is to regulate the medical technology industry 
to ensure health & safety of the consumers as well as the actors involved in the 
value/supply chain. There are also influences from other external stakeholders. For 
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example, a legislation to prevent injuries to healthcare workers caused by sharps, 
including syringes was adapted due to the influence of unions (EPSU and HOSPEEM). 
Another important interrelation in this area is the authorised power given to notified 
bodies by MHRA (UK competent authority). Notified bodies carry out certain 
conformity assessments required at the pre-market approval stage. 
 
Another key actor important for the overall dynamics of an industry is the networking 
organisations. For example, the main role of KTN is to transfer knowledge between 
external stakeholders and industrial actors regarding research partnerships, regulation 
change, funding opportunities etc. Due to the high percentage of SMEs in the UKMTS, 
there are also significant specialist service activities. It was stated by the Head of Health 
from KTN as, “All the way along the value chain, SMEs need help through consultancy 
service, whereas big companies have in-house ability for various process such as R&D 
and manufacturing scale up”. 
 
4.1.2  Infrastructural Characteristics 
 
Industrial Actors: Generally, industrial actors involved in the R&D and design are the 
OEMs. It was observed for PCR, SMBG and syringe industrial systems that some 
OEMs choose to outsource this stage to ODMs. From the forceps case study, it was 
observed that machined parts supplier could also be involved. For the pre-market 
approval stage, more actors are generally involved for the IVD segment since products 
tend to be more innovative than the SUI segment, requiring more rigorous approval 
stages with multiple actors. Generally, a higher geographical presence of MNCs was 
observed for all products except for the forceps industrial system. It is noted that most 
MNCs only have a sales division in the UK and only few production facilities were 
observed for PCR and SMBG reagents. For the forceps, there are mainly two types of 
UK manufactures, OEMs and OBMs in which the latter have agreements with external 
manufactures to put their own label. In both cases, highest portion of machined parts 
comes from Sialkot, Pakistan where it has a significant surgical equipment 
manufacturing market (Managing Director, Forceps Manufacture). Due to the product 
characteristics of the PCR and SMBG systems, there are various industrial actors 
involved in the market, whereas SUIs are primary used for clinical purpose by 
healthcare providers. For the end of life, waste management providers are the main 
actors in the syringe industrial system, whereas there are multiple actor types involved 
in the other three products due to the different end of life options. 
 
External Stakeholder Involvement and Product/Service Quality: Generally, it was 
observed that there is a difference in the external stakeholders involved and their focus 
in the two segments analysed. For example, more actors are involved for the PCR and 
SMBG industrial system as these diagnostics functions are important in reducing 
immunology/diabetes epidemics. As a result, there are more research, funding 
opportunities and Global Health NGOs involved in these fields. For the SUIs, there is a 
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high focus on contamination and blood-borne diseases. For example, Sharps Regulation 
was introduced from the influence of unions for this purpose. Research focuses on 
decontamination such as the radiofrequency (RF) gas-plasma technology developed by 
the University of Edinburgh to sterilise metal surgical instruments (The University of 
Edinburgh, 2006). 
 
Since medical technology has a significant impact on the patient’s health & safety, the 
product quality is maintained through strict regulations and quality management 
standards (e.g. ISO 9001 / 13485) formed by the International Organization of 
Standardization (ISO). Due to the different risks the two segments pose to the patients, 
IVDD is in charge of regulatory compliance for diagnostic purpose PCR and SMBG 
system (excluding lancet), whereas MDD is responsible for SMBG lancet, syringe and 
forceps. The difference in risk was explained by a Regulatory Affairs Manager in 
EDMA that, “If a MD doesn’t work, it can cause physical harm to a patient whereas if 
there is a faulty result from an IVD test (e.g. for HIV), the patient can spread the 
disease”. Due to the user characteristics of a SMBG system as the general public, there 
is a further emphasis on data accuracy through ISO 15197 aiming to reduce its risks. 
 
New Product/Process Development: The new product development focus is rather 
different for all products. For a PCR system, the focus is on higher efficiency (e.g. 
speed of test), new PCR platform or new assay test development. For a SMBG system, 
one focus is on next-generation sensing technology that can improve the accuracy. An 
injection system that does not provide discomfort is a common theme between the 
lancets used in SMBG system and syringes. The latter has a further focus on the 
shielding mechanism to protect the healthcare providers from blood-borne diseases. For 
the forceps, one focus is on new polymer materials that have similar strength properties 
to stainless steel. In terms of NPD, there is an on-going discussion since 2012 to review 
the current MDD and IVDD directives. These will pose a more rigorous regulation and 
influence the way notified body functions, ultimately affecting the individual VC/SC as 
well as product characteristics for all product-based industrial systems.  
 
4.2 Environmental sustainability Dynamics 
 
Environmental sustainability dynamics at the Institution/Specialist Level: Governmental 
policies are encouraging basic/applied research councils as well as commercial research 
funding to change their involvement through product innovation and funding projects 
that are aligned with the environmental policies. Regarding commercial funding, it was 
stated by the Head of Sustainability of the Technology Strategy Board - “The goal is to 
build sustainability and resource efficiency in the UK economy through mainly funding 
projects that are relative to the circular economy and assist in transforming the 
industrial system”. These research/funding activities aim to influence industrial actors 
in an infrastructural way through encouraging a change in product/service quality, new 
products/processes based on the circular economy, change of actors etc. Environmental 
policies are influencing regulators to change their involvement with industrial actors 
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through setting revised regulations and standards. Another example of an infrastructural 
influence of environmental policies and legislation can be seen from the Sustainable 
Development Unit (SDU). SDU is a specialist service provider that develops tools, 
strategies and research that will enable UKMTS actors to promote sustainable 
development. The SDU’s Head of Unit stated, “Due to the UK being the only European 
country which has a legislation on the carbon footprint reduction from the Climate 
Change Act, it was a good entry point for SDU to first tackle this, whereas other EU 
countries may be looking at toxicity first”. There are various other infrastructural 
influences regarding environmental sustainability at the institution/specialist level that 
are captured in figure 2. It can be concluded that the majority of the environmental 
sustainability activities in the institutional/specialist level are aimed to influence the 
structure of the UKMTS System indirectly.  
 
Environmental sustainability dynamics at VC/SC and Industrial Actor Levels: It was 
observed that infrastructural influences from the institutions/specialists could be 
translated into green strategies, which will encourage new processes/products to be 
developed internally. An example is the E-procurement strategy revised to be placed 
between different actors along the supply chain in order to influence the infrastructure 
by encouraging a more resource efficient procurement process, stated by a Senior 
Quality Manager, Forceps Manufacture. Comparing SMEs and MNCs, a different 
approach to environmental sustainability was observed. A Sustainable Policy Assistant 
from a Medical Technology MNC has stated, “Amongst medical technology companies, 
all comply with environmental legislation, with some looking at it as an opportunity 
such as Johnson & Johnson (J&J), Baxter and BD”. In contrast, it was stated by a 
Policy Advisor in the Association of British Healthcare Industry (ABHI), “With most 
UK based medical device companies being SMEs, there is not a high focus on 
environmental sustainability compared to other industries such as Food and Retail”. 
For example, it was observed that SMEs had a lower implementation rate for 
environmental management system such as ISO 14001 compared to the MNCs. 
However, it was found from an interview with a Manager of a PCR Instrument Supplier 
that they have implemented ISO 14001 to reduce their carbon footprint from the 
funding scheme - ‘Low Carbon Keep Project’, supported by the European Regional 
Development Fund. Outcomes from the new product/processes developed from the 
influence of green strategies in both VC/SC and industrial actor level were observed to 
have structural influence (e.g. product characteristics, VC/SC process, capacity) 
targeted at certain parts of the value/supply chain. Due to the nature of waste generated 
through consumables used in the PCR and SMBG system, emphasis on the resource 
efficiency through eco design were observed. Similarly for the SMBG system, some 
companies are also looking into design for waste minimisation. For example, Roche has 
introduced a SMBG system that uses a cartridge system containing 50 tests, reducing 
the need to dispose each test strip. There are other companies looking into similar 
methods, and these activities can potentially have a structural influence on the product 
specific industrial system. Compared to the PCR and SMBG systems that have a 
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relatively effective recycling system implemented due to regulatory compliance, 
product recovery for syringes and forceps are considered to be poor. A Managing 
director of a Forceps Manufacturer has stated, “Single use forceps are usually made 
from 401 stainless steel, which has fair second hand value that can be used for kitchen 
knives, but there is a massive gap in the UK market for recycling”. The main reason for 
this was explained by a Clinical Waste Manager in a Waste Management Provider as, 
“The challenge is within proper segregation at the source to stop material from getting 
into the waste stream since the containers are not allowed to be reopened after sealing, 
ending up with the material being sent for incineration”. This leads to the importance of 
VC/SC level green waste management activity as an issue which can be resolved 
through partnering with a hospital to segregate, sterilise and send material to scrap for 
recycling. In the case of syringes, there is a high barrier to product recovery due to the 
significance of blood-borne diseases and the difficulty in recovering a product with 
multiple materials. One initiative observed was from Sharpsmart -  reducing waste 
through reusable sharps bins, which can create a 25% reduction in the volume of plastic 
in sharps waste. Both forceps and syringes green waste management activities can have 
a structural influence on the value chain, as well as a change in roles and relations 
between waste management providers and hospitals. There are various other structural 
influences regarding environmental sustainability at the VC/SC/actors level that are 
captured in figure 3. 
  
5 Conclusion  
 
The current UKMTS industrial system is not very proactive in terms of environmental 
sustainability in comparison to other industries such as automotive, food and retail. 
Analysis of the dynamics of environmental sustainability in the UKMTS industrial 
system illustrates that industrial actors require infrastructural influences from the 
existing external stakeholder to ultimately restructure the industrial system. As the 
UKMTS consists of 99% SMEs, this creates a significant challenge to implement 
environmental sustainability. It suggests there is a need that SMEs must be the central 
target of infrastructural influence by external stakeholders through research funding, 
regulation, collaboration etc. There is also specific difficulty in influencing the 
industrial actors through regulation in the UKMTS. There is a requirement for a more 
specific infrastructural influence for each product-based system from the external 
stakeholders, to effectively restructure the UKMTS. There are few MNCs collaborating 
with suppliers to identify opportunities across the value chain or hospitals and waste 
management companies collaborating toward increased product recovery and reduced 
carbon footprint? This research positions contextual/business environmental elements of 
operation management into more dominant elements of an operational system. This was 
performed through a structure and infrastructure perspective on industrial systems 
frameworks, with specific emphasis on its dynamics/influences when approaching an 
industrial scale challenge. From the analysis of dynamics between environmental 
sustainability and industrial systems, it was found that external stakeholders make 
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infrastructural decisions that enable industrial actors to influence the industrial system 
structure directly through a ‘carrot’ and ‘stick’ approach. Further research on the 
industrial systems of the UK Medical Technology Sector and other sectors are 
recommended for additional support of the data as well as to justify this new approach. 
 
 
Appendix1  
 
No. Corresponding Source  
1 (Glavič & Lukman, 2007) 
2 (Marteel et al., 2003) 
3 (Joshi, 2000) 
4 (Orsato, 2006) 
5 (Linton et al., 2007) 
6 (Srivastava, 2007) 
7 (Guide et al., 2003) 
8 (Kleindorfer et al., 2005) 
9 (Vachon & Klassen, 2006) 
10 (Wang & Côté, 2011) 
11 (Braungart & McDonough, 2002) 
12 (Braungart et al., 2007) 
13 (Guide & Wassenhove, 2001) 
14 (Ferrer, 2001) 
15 (Moore et al., 2001) 
16 (Nagel & Meyer, 1999) 
17 (Tsoulfas & Pappis, 2006) 
18 (Platcheck et al., 2008) 
19 (Gottberg et al., 2006) 
20 (Smith & Yen, 2010) 
21 (Wang & Côté, 2011)  
22 (Holdway et al., 2002) 
23 (Krikke et al., 1999) 
24 (Klemm et al., 2005) 
25 (Pol, 2010) 
26 (Martin & Eklund, 2011) 
27 (Linton et al., 2007) 
28 (Chertow, 2000) 
  
  
  
29 (Cohen-Rosenthal, 2004) 
30 (Baines et al., 2012) 
31 (Frondel et al., 2007) 
32 (Vachon & Klassen, 2006) 
33 (Marchi et al., 2013) 
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34 (Jacobsson & Lauber, 2006) 
35 (Bovea & Gallardo, 2006) 
36 (Martin & Eklund, 2011) 
37 (Hwang et al., 2010) 
38 (Yuan et al., 2006) 
39 (Geng & Doberstein, 2008) 
40 (Gravitis et al., 2004) 
41 (Mueller et al., 2009) 
42 (Grepperud, 2002) 
43 (Iraldo et al., 2009) 
44 (Rennings et al., 2006) 
45 (Delmas & Montiel, 2008) 
46 (Seyfang, 2006) 
47 (Yang & Percival, 2009) 
48 (Rondinelli & Vastag, 2000) 
49 (Martin, 1992) 
50 (Murphy & Gouldson, 2000) 
51 (Gouldson & Murphy, 1996) 
52 (Erkman, 1997) 
53 (Southerton et al., 2004) 
54 (Baines et al., 2007) 
55 (Tridech & Cheng, 2010) 
56 (Srai et al., 2013) 
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